Picture of Cryolife heart valve in this month's Discover Magazine
Pretty pictures and life saving products, in and of themselves, do not put money in the bank.
Historically CRY's tissue business has contributed very little "net cash flow". This is the reason for my question.
Question: Is this product going to generate significant future "net cash flow"? Yes/No, when, and how much?
When you listen to SGA and DAL during the Q3 2010 conference call, they will either tell those listening what the margins are on this product, or they will just talk about the product itself. If they only talk about the product itself, but are not specific as to margins, you will know it is a low profitability product. If they give us the specifics on margins, then I will believe their numbers until proven otherwise.